Downloads provided by UsageCounts
Oxidative stress triggers nonalcoohlic steatohepatitis (NASH) and liver fibrosis. Nuclear-erythroid-2-Related Factor 2 (NRF2) is the master regulation of the anti-oxidant response. In this study, we tested the therapeutic potential of a new NRF2 activator (S217879) in Precision Cut Liver Slices (PCLS) derived from the liver of patients with metabolic associated fatty liver disease (MAFLD), and compared its effects to those of the well-known PPARa/d agonist, Elafibranor.
Oxidative stress, NASH, MAFLD, S217879, Elafibranor, NRF2
Oxidative stress, NASH, MAFLD, S217879, Elafibranor, NRF2
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 7 | |
| downloads | 3 |

Views provided by UsageCounts
Downloads provided by UsageCounts